Developer docs
API playgroundTry for free, no card

Search company profiles

iCAN: israel-cannabis.com

Full company profile

uuid00045ne

Namestring
iCAN: israel-cannabis.com
Company typeenum
Private
Founded yearint
2015
Short descriptiontext

iCAN: israel-cannabis.com is a private, Israel-based cannabis accelerator founded in 2015 in Beit Shemesh that invests in cannabis products and solutions, with a small team led by founders Saul Kaye (CEO) and Jason Ryker (COO).

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBeit-shemesh, Israel
HQ citystring
Beit-shemesh
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
cannabis accelerator, cannabis investment, cannabis services, cannabis venture funding, cannabis product solutions
Product category
Cannabis Industry Services & Investment
Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

iCAN is an Israel-based accelerator and services company that invests in cannabis products and solutions. It provides capital, operational support, and services to cannabis-focused ventures, primarily within the Israeli cannabis ecosystem. The company also functions as a holding and investment vehicle that channels funding from sources such as Tress Capital into portfolio companies.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Cannabis Accelerator Program
CategoryCannabis Industry Services
2Cannabis Venture Investment
CategoryCannabis Investment
No data
Peers10 records
TypeBroad incumbent
Description

Canopy Growth is a global cannabis MSO with extensive cultivation and branded product operations. It is comparable only at the broadest industry level, as a cannabis-sector incumbent rather than a direct accelerator peer to iCAN.

TypeBroad incumbent
Description

Acreage Holdings is a multi-state cannabis operator with cultivation, processing, and retail operations. It is broadly comparable as a cannabis-sector incumbent but operates at significantly larger MSO scale rather than as an accelerator or investor.

TypeBroad incumbent
Description

Leafly is a leading cannabis information and consumer marketplace platform. It is broadly comparable to iCAN as a cannabis ecosystem enabler, though Leafly operates at consumer scale via discovery and retail listings rather than early-stage investment.

TypeDirect peer
Description

Tress Capital is a cannabis-focused private equity and venture firm that has directly invested in iCAN. It is a direct peer because both allocate capital to cannabis businesses and share an overlapping investor mandate and deal-flow network.

TypeBroad incumbent
Description

Weedmaps is a major cannabis marketplace and SaaS platform connecting consumers and retailers. It is broadly comparable to iCAN as both operate within cannabis commerce infrastructure, but Weedmaps does so via listings and software rather than accelerator capital.

TypeOthers
Description

High Times is a long-running cannabis media and events brand. It is an adjacent peer to iCAN as a cannabis ecosystem participant with media, events, and capital-introduction activities, though it does not operate as an early-stage accelerator.

TypeOthers
Description

Marijuana Business Daily provides news, data, and events for the cannabis industry. It is an adjacent peer to iCAN as a cannabis information and capital-introduction provider that overlaps with iCAN's investor-relations and ecosystem-credibility functions.

TypeDirect peer
Description

Phyto Partners is a cannabis-focused venture capital and growth equity firm. It is directly comparable to iCAN because both deploy capital into cannabis companies with a similar investment thesis around ancillary products, services, and emerging cannabis categories.

TypeDirect peer
Description

CanopyBoulder is a US-based cannabis technology accelerator and seed fund. It is directly comparable to iCAN as both operate cannabis-focused accelerators backing early-stage companies, with similar deal-flow sourcing, mentorship models, and target portfolio profiles.

TypeEmerging player
Description

PanXchange operates B2B commodities trading platforms with material cannabis, hemp, and CBD exposure. It is an emerging peer because it serves as infrastructure within the cannabis commercial ecosystem, intersecting with iCAN's portfolio companies but operating a marketplace rather than an accelerator model.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

iCAN: israel-cannabis.com

Cannabis Industry Services & Investmentisrael-cannabis.com

iCAN: israel-cannabis.com is a private, Israel-based cannabis accelerator founded in 2015 in Beit Shemesh that invests in cannabis products and solutions, with a small team led by founders Saul Kaye (CEO) and Jason Ryker (COO).

iCAN: israel-cannabis.com firmographics

Firmographics
Name
iCAN: israel-cannabis.com
Website
https://israel-cannabis.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
iCAN: israel-cannabis.com is a private, Israel-based cannabis accelerator founded in 2015 in Beit Shemesh that invests in cannabis products and solutions, with a small team led by founders Saul Kaye (CEO) and Jason Ryker (COO).
Ownership category
akta.pro rank

Where iCAN: israel-cannabis.com is headquartered

Location

Headquarters

HQ city
Beit-shemesh
HQ country
Israel
HQ region
Middle East

Markets served

iCAN: israel-cannabis.com business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

iCAN: israel-cannabis.com product offering

Product offering

Core offering

iCAN is an Israel-based accelerator and services company that invests in cannabis products and solutions. It provides capital, operational support, and services to cannabis-focused ventures, primarily within the Israeli cannabis ecosystem. The company also functions as a holding and investment vehicle that channels funding from sources such as Tress Capital into portfolio companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cannabis Accelerator Program
  • Cannabis Venture Investment

Companies that use iCAN: israel-cannabis.com

Customer profile

Ideal customer profiles1 record

iCAN: israel-cannabis.com technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

iCAN: israel-cannabis.com competitors and assessment

Company assessment

Broad incumbents

  • Canopy Growth Corporation: Canopy Growth is a global cannabis MSO with extensive cultivation and branded product operations. It is comparable only at the broadest industry level, as a cannabis-sector incumbent rather than a direct accelerator peer to iCAN.
  • Acreage Holdings: Acreage Holdings is a multi-state cannabis operator with cultivation, processing, and retail operations. It is broadly comparable as a cannabis-sector incumbent but operates at significantly larger MSO scale rather than as an accelerator or investor.
  • Leafly Holdings: Leafly is a leading cannabis information and consumer marketplace platform. It is broadly comparable to iCAN as a cannabis ecosystem enabler, though Leafly operates at consumer scale via discovery and retail listings rather than early-stage investment.
  • Weedmaps: Weedmaps is a major cannabis marketplace and SaaS platform connecting consumers and retailers. It is broadly comparable to iCAN as both operate within cannabis commerce infrastructure, but Weedmaps does so via listings and software rather than accelerator capital.

Direct peers

  • Tress Capital: Tress Capital is a cannabis-focused private equity and venture firm that has directly invested in iCAN. It is a direct peer because both allocate capital to cannabis businesses and share an overlapping investor mandate and deal-flow network.
  • Phyto Partners: Phyto Partners is a cannabis-focused venture capital and growth equity firm. It is directly comparable to iCAN because both deploy capital into cannabis companies with a similar investment thesis around ancillary products, services, and emerging cannabis categories.
  • CanopyBoulder: CanopyBoulder is a US-based cannabis technology accelerator and seed fund. It is directly comparable to iCAN as both operate cannabis-focused accelerators backing early-stage companies, with similar deal-flow sourcing, mentorship models, and target portfolio profiles.

Others

  • High Times: High Times is a long-running cannabis media and events brand. It is an adjacent peer to iCAN as a cannabis ecosystem participant with media, events, and capital-introduction activities, though it does not operate as an early-stage accelerator.
  • Marijuana Business Daily: Marijuana Business Daily provides news, data, and events for the cannabis industry. It is an adjacent peer to iCAN as a cannabis information and capital-introduction provider that overlaps with iCAN's investor-relations and ecosystem-credibility functions.

Emerging players

  • PanXchange: PanXchange operates B2B commodities trading platforms with material cannabis, hemp, and CBD exposure. It is an emerging peer because it serves as infrastructure within the cannabis commercial ecosystem, intersecting with iCAN's portfolio companies but operating a marketplace rather than an accelerator model.

Market position

Customer concentration

iCAN: israel-cannabis.com social profiles

Digital presence

iCAN: israel-cannabis.com financial estimates

Financial estimate

Revenue estimate

Valuation estimate

iCAN: israel-cannabis.com leadership team

Management profile

Number of profiles

Profiles2 records

iCAN: israel-cannabis.com funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

iCAN: israel-cannabis.com M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iCAN: israel-cannabis.com

What does iCAN: israel-cannabis.com do?

iCAN is an Israel-based accelerator and services company that invests in cannabis products and solutions. It provides capital, operational support, and services to cannabis-focused ventures, primarily within the Israeli cannabis ecosystem. The company also functions as a holding and investment vehicle that channels funding from sources such as Tress Capital into portfolio companies.

When was iCAN: israel-cannabis.com founded?

iCAN: israel-cannabis.com was founded in 2015. It employs 11 to 50 people.

Where is iCAN: israel-cannabis.com based?

iCAN: israel-cannabis.com is headquartered in Beit-shemesh, Israel, in the Middle East region.

Who are iCAN: israel-cannabis.com's main competitors?

Broad incumbents on record are Canopy Growth Corporation, Acreage Holdings, Leafly Holdings and Weedmaps. Direct peers are Tress Capital, Phyto Partners and CanopyBoulder. Others are High Times and Marijuana Business Daily. PanXchange is listed as an emerging player.

Does iCAN: israel-cannabis.com have an API?

No public API is recorded for iCAN: israel-cannabis.com.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireiCAN: Israel-Cannabis and Headquarters Announce Strategic Partnership to Introduce Israeli Cannabis Innovations and Companies to the California MarketiCAN: Israel-Cannabis, Israel's leading cannabis incubator, has formed a strategic partnership with Headquarters (HQ), a Los Angeles-based product accelerator and cannabis license holder, to introduce Israeli cannabis innovations to the California market. The partnership will provide Israeli cannabis companies with access to HQ's distribution, sales, and manufacturing infrastructure, leveraging California's $2 billion annual cannabis market. The collaboration aims to establish a "cannabis bridge" between Israel and California, with HQ offering a six-month accelerator program to help businesses enter the market.PR NewswireiCAN: Israel-Cannabis CEO & Founder Saul Kaye to Participate at the Cannabis Europa Conference in LondonSaul Kaye, CEO and founder of iCAN: Israel Cannabis, will participate as a panelist at the upcoming Cannabis Europa Conference in London to discuss health tech and patient empowerment. The session aims to explore the role of technology and blockchain in standardizing the cannabis industry amidst growing European legalization trends.PR NewswireiCAN: Israel-Cannabis CEO and Founder Saul Kaye to Participate at the World Cannabis Congress in Saint John, New BrunswickSaul Kaye, CEO and founder of iCAN: Israel Cannabis, will participate as a moderator at the World Cannabis Congress in Saint John, Canada, from June 16-18, 2019. He will lead a session on innovative methodologies in global cannabis research alongside experts from the Scottsdale Research Institute and CFS. The event serves as a gathering for international leaders to discuss developments in the medical and business aspects of the cannabis industry.PR NewswireCannabisBPO, CannaTech, and iCAN: Israel Cannabis Expands PartnershipCannabisBPO announced the expansion of its partnership with CannaTech and iCAN: Israel Cannabis to provide specialized multi-channel contact center services for the global cannabis industry. Under the expanded agreement, companies within the iCAN incubator program will gain access to contact center solutions at entrepreneur relationship rates. CannabisBPO is a sponsor of CannaTech Tel Aviv, scheduled for April 1-3, 2019 at Tel Aviv Port.PR NewswireNew to the iCAN: Israel-Cannabis Incubator: Cann2Go, Software that Optimizes Last Mile Delivery of Medical CannabisCann2Go, a startup developing a SaaS platform for medical cannabis last-mile delivery, has joined the iCAN: Israel-Cannabis Incubator. The platform utilizes algorithms to optimize routing and tracking for cannabis distribution companies in Israel. Cann2Go is currently seeking strategic investment for global deployment.GlobeNewswireThe Greater Cannabis Company Announces Distribution Agreement With Leading Global Cannabis Company iCAN: Israel Cannabis Ltd.Greater Cannabis Company entered a letter of intent with iCAN Cannabis to expand distribution of its eluting patch platform into key global markets. The agreement covers Israel, Australia, South Africa, Netherlands, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia, and Portuguese territories. The company aims to accelerate commercialization of its patented delivery system.PR NewswireiCAN: Israel Cannabis CEO: "Cannabis to Become as Important to Israel's Economy as High-Tech"Israel's Knesset has approved the export of medical cannabis, enabling the country to participate in the global cannabis market projected to reach $33 billion worldwide in the next five years. Saul Kaye, CEO of iCAN: Israel-Cannabis, welcomed the development and stated that Israel, already a leader in cannabis R&D, expects over $1 billion in domestic sales alone. The new law requires the Interior Ministry and Israeli Police to monitor production and export, mandates regulatory approval for foreign investments exceeding 5% in Israeli cannabis companies, and iCAN has partnered with Theracann to provide tracking technology for compliance.PR NewswirePanama's First Ever Global Medical Cannabis Summit Panama City, February 13-14, 2019iCAN: Israel-Cannabis announced that Panama will host its first-ever Medical Cannabis Summit, CannaTech Panama, on February 13-14, 2019 at the Central Hotel in Casco Viejo, Panama City. The summit will bring together industry leaders from Latin America and worldwide to discuss agricultural tech, business, finance, policy, and medical cannabis science. According to research consultancy Prohibition Partners, the Latin American cannabis market is projected to reach $12.7 billion by 2028, with the medical cannabis segment estimated at $8.5 billion within the decade.PR NewswireiCAN Signs Bilateral Service Agreement With Global Technology CompanyiCAN: Israel-Cannabis, a Tel Aviv-based technology incubator for medical cannabis, announced the signing of a bilateral service agreement and strategic alliance with TheraCann International Benchmark Corporation, a North American cannabis technology company. Under the agreement, iCAN will deliver TheraCann's Electronic Traceability for Cannabis and Hemp (ETCH) biotrace technology to emerging markets in Europe, Africa, and Asia while providing Theracann's clients access to iCAN's technology portfolio and its global CannaTech conference network. The partnership aims to expand both companies' operational footprints across multiple global cannabis markets.PR NewswireiCAN: New Medical Cannabis Technology Company From Poland Joins iCAN: Israel-Cannabis' Incubator Cannabinit Produces Cannabis Plant Cells in VitroIsrael-Cannabis has partnered with Polish entrepreneur Rafał Ślusarczyk to establish Cannabinit, a new company utilizing technology to produce medical cannabis plant cells in vitro without growing whole plants. The venture aims to lower maintenance costs and ensure standardized extracts, having recently won first place at the CannX Medical Cannabis Conference. Cannabinit will join iCAN's incubator portfolio to further develop this technology for the Polish pharmaceutical market.